Sunday, April 20, 2014

Mirena Lawsuits Move Forward in New Jersey Litigation, As Court Schedules May Conference, Bernstein Liebhard LLP Reports

The Firm is representing clients who filed Mirena IUD lawsuits in this proceeding after allegedly suffering serious Mirena complications that followed spontaneous migration of the device.

New York, New York (PRWEB) April 18, 2014
More than 700 Mirena lawsuits ( filed on behalf of women who were allegedly injured due to spontaneous migration of the IUD continue to move forward in a consolidated litigation underway in New Jersey’s Bergen County Superior Court, Bernstein Liebhard LLP reports. Court documents indicate that the proceeding’s next Case Management Conference has been scheduled for May 13, 2014, at 2:00 p.m. According to an Order dated April 1, 2014, the parties have been directed to submit a proposed agenda to the Court at least seven days prior to the conference. (In Re: Mirena Litigation; Case No. 297)
“Our Firm is representing numerous women in this proceeding who allegedly suffered serious Mirena complications after their IUD spontaneously migrated from its proper position in the uterus. We are pleased to see this litigation moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Mirena lawsuit evaluations to women who may have been injured due to the spontaneous migration of their IUD.
Mirena IUD Lawsuits
The Mirena IUD is a long-acting contraceptive device that is manufactured by Bayer Healthcare Pharmaceuticals. The product was initially approved as a method of birth control in 2000 by the U.S. Food & Drug Administration (FDA), which in 2009 expanded its approved uses to include the treatment of heavy menstrual bleeding in women who wish to use an IUD as their method of contraception. According to a report that aired on 7 Action News this past summer, the U.S. Food & Drug Administration (FDA) has received more than 70,000 complaints involving Mirena, including thousands that detail cases of device dislocation and uterine perforation, since the IUD was first launched.*
In December 2009, the FDA issued a Warning Letter to Bayer Healthcare Pharmaceuticals after finding that one of the company’s Mirena promotions made misleading claims about the safety and efficacy of the IUD.
According to court documents, all of the Mirena lawsuits pending in the New Jersey litigation allege that plaintiffs sustained uterine perforations, adhesions, infections, and other serious Mirena complications due to spontaneous migration of the IUD, even though the device had been properly inserted by a healthcare provider. The lawsuits further allege that Bayer has a history of overstating the IUD’s benefits and downplaying its risks. Finally, plaintiffs claim that the company has not provided adequate warnings regarding its propensity to spontaneous migrate from its proper position in the uterus, and point out that the Mirena label only states that migration may occur if the uterus is punctured during insertion.
Court records indicate that more than 1,000 lawsuits involving alleged Mirena complications are now pending in courts throughout the country. In addition to the New Jersey litigation, nearly 500 additional lawsuits have been consolidated for pretrial proceedings in the U.S. District Court, Southern District of New York. (In re: Mirena IUD Products Liability Litigation, MDL No. 2434)
Women who have allegedly experienced serious Mirena complications related to spontaneous migration of the IUD may be entitled to financial compensation for their injury-related damages. Learn more about potential Mirena complications at Bernstein Liebhard LLP’s website, or visit the Firm’s Facebook page: For a free legal consultation, please call 800-511-5092.
*, 7 Action News, August 27, 2013
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since the list was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

No comments: